PBH — Prestige Consumer Healthcare Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1295947 ·
Last close
$48.02
Market Cap
$2.27B
52W High
$70.02
52W Low
$42.62
ADV30
695,440
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 281,617,000 | 146,299,000 | 75,492,000 | 53,928,000 | 3,494,313,000 | 63,868,000 | 1,606,797,000 |
| Dec 2025 | 283,444,000 | 157,369,000 | 82,491,000 | 46,696,000 | 3,494,743,000 | 62,373,000 | 1,665,292,000 |
| Sep 2025 | 274,114,000 | 151,579,000 | 79,670,000 | 42,211,000 | 3,442,280,000 | 119,106,000 | 1,617,311,000 |
| Jun 2025 | 249,530,000 | 140,331,000 | 71,756,000 | 47,466,000 | 3,431,625,000 | 139,502,000 | 1,576,143,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$276,634,000
Investing CF
$-136,906,000
Financing CF
$-129,451,000
CapEx
$-9,447,000
Dividends Paid
—
Buybacks
$-166,906,000
EPS Diluted TTM
$4.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$1,692,175,000
Inventory
$163,594,000
Receivables
$190,456,000
ST Investments
—
EBIT TTM
$308,353,000
Pretax Income TTM
$266,683,000
Interest Exp TTM
$41,670,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,088,705,024
EBITDA
$340,681,984
Free Cash Flow
$192,759,744
Enterprise Value
$3,255,424,000
Total Cash
$63,868,000
Total Debt
$1,045,427,968
Shares Out
47,372,166
Trailing EPS
$3.91
Book Value
$38.66
ROE
10.2%
ROA
5.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,088,705,000 | 309,409,000 | 190,301,000 | 3,494,313,000 | 1,606,797,000 | — | 257,627,000 |
| Mar 2025 | 1,137,762,000 | 349,241,000 | 214,605,000 | 3,402,218,000 | 1,567,321,000 | — | 251,515,000 |
| Mar 2024 | 1,125,357,000 | 342,429,000 | 209,339,000 | 3,318,417,000 | 1,663,333,000 | — | 248,926,000 |
| Mar 2023 | 1,127,725,000 | 347,802,000 | -82,306,000 | 3,353,729,000 | 1,906,645,000 | — | 229,716,000 |
TTM Snapshot
Revenues TTM
$1,123,052,000
NetIncome TTM
$216,244,000
OpCashFlow TTM
$0
Assets (Latest)
$3,402,218,000
Forward EPS
$5.07
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $2.28B | $23.14 | — |
| GIFOF | Grifols SA | $2.29B | $8.85 | — |
| NKTR | NEKTAR THERAPEUTICS | $2.22B | $65.56 | — |
| KNSA | Kiniksa Pharmaceuticals International, plc | $2.45B | $52.86 | — |
| VERA | Vera Therapeutics, Inc. | $2.47B | $34.34 | — |
News headlines (Yahoo Finance, 1h cache)
Prestige Consumer Healthcare Inc. Just Missed Earnings - But Analysts Have Updated Their Models
2026-05-15 12:50 · Yahoo
Prestige Consumer Healthcare Q4 Earnings Call Highlights
2026-05-15 07:07 · Yahoo
Prestige Consumer Healthcare Inc (PBH) Q4 2026 Earnings Call Highlights: Navigating Challenges ...
2026-05-14 23:02 · Yahoo
Sector Update: Healthcare Stocks Mixed Late Afternoon
2026-05-14 19:48 · Yahoo
Prestige Consumer Healthcare Attributes Soft Results to Low Eye Care Sales, Weak Consumer Backdrop
2026-05-14 17:44 · Yahoo
Sector Update: Healthcare Stocks Softer Thursday Afternoon
2026-05-14 17:43 · Yahoo
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down
2026-05-14 17:08 · Yahoo
Prestige Consumer Faces Execution Pressure After Weak Q4, Softer 2026 Outlook, Oppenheimer Says
2026-05-14 15:13 · Yahoo
Prestige Consumer Healthcare (PBH) Q4 Earnings and Revenues Lag Estimates
2026-05-13 22:10 · Yahoo
Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say
2026-05-13 22:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.